This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Eli Lilly and Co (LLY)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 2.39B 4.68B 4.09B 4.35B
Operating Gains/Losses 145.60M 37.10M 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 117.40M -152.70M 361.80M -188.80M
(Increase) Decrease in Inventories -307.10M -286.50M -307.90M 203.10M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -260.70M -70.30M -336.10M 591.40M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 411.50M 116.50M 231.00M 642.70M
Other Non-Cash Items 527.30M -325.40M -320.80M 533.30M
Net Cash From Continuing Operations 4.37B 5.74B 5.30B 7.23B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 4.37B 5.74B 5.30B 7.23B
Sale of Property, Plant & Equipment 15.30M 179.40M 1.23B 25.30M
Cash Used for Investing Activities
Sale of Short-Term Investments 4.05B 3.32B 0.00 0.00
Purchases of Property, Plant & Equipment -1.47B -1.09B -1.04B -1.69B
Acquisitions -551.40M -43.70M -199.30M -307.80M
Purchases of Short-Term Investments -1.64B 0.00 0.00 0.00
Other Cash from Investing Activities -5.53B -1.63B 439.50M -528.10M
Cash Provided by Financing Activities
Net Cash From Investing Activities -3.91B -2.07B -2.83B -4.82B
Issuance of Debt 992.90M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 0.00 0.00 0.00
Repayment of Long-Term Debt -1.03B -10.50M -1.50B -54.60M
Repurchase of Capital Stock -800.00M -1.70B -721.10M 0.00
Payment of Cash Dividends -2.10B -2.12B -2.19B -2.18B
Other Financing Charges, Net 2.87B 0.00 -10.50M -135.20M
Net Cash From Financing Activities -75.10M -3.83B -4.42B -2.37B
Effect of Exchange Rate Changes -341.50M -21.50M 43.90M -110.90M
Net Change in Cash & Cash Equivalents 41.40M -188.60M -1.90B -70.70M
LLY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LLY Eli Lilly and Co

Chart of LLY

Analysts Ratings for LLY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 8 7
Moderate Buy 0 0 0 0
Hold 3 3 4 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

LLY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs